Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer’s disease

By Summer L. Bernstein, N. Dupuis, N. Lazo, T. Wyttenbach, M. Condron, G. Bitan, David B. Teplow, J. Shea, B. Ruotolo, Carol V. Robinson and 1 more. Nature Chemistry, 2009

839 citations recorded by the source corpus.

In recent years, small protein oligomers have been implicated in the aetiology of a number of important amyloid diseases, such as type 2 diabetes, Parkinson’s disease and Alzheimer’s disease. As a consequence, research efforts are being directed away from traditional targets, such as amyloid plaques, and towards characterization of early oligomer states. Here we present a new analysis method, ion mobility coupled with mass spectrometry, for this challenging problem, which allows determination of in vitro oligomer distributions and the qualitative structure of each of the aggregates. We applied these methods to a number of the amyloid-β protein isoforms of Aβ40 and Aβ42 and showed that their oligomer-size distributions are very different. Our results are consistent with previous observations that Aβ40 and Aβ42 self-assemble via different pathways and provide a candidate in the Aβ42 dodecamer for the primary toxic species in Alzheimer’s disease.

Subfields: Molecular Biology, Physiology

View Paper: https://www.semanticscholar.org/paper/9a74bb4f88988878519ef467345cda70e7bd79e6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

  1. E. Thies
  2. H. Zempel
  3. E. Mandelkow

In Physiology

  1. E. Mandelkow
  2. E. Thies
  3. H. Zempel
  4. R. Vale

Citations in the corpus